Operation Warp Speed worked so well to accelerate the development of COVID-19 vaccines the FDA now has its sights set on a similar initiative for rare disease treatments.
https://www.pharmalive.com/wp-content/uploads/2023/04/BioSpaceWarp4-24-2023.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2023-04-24 11:13:312023-04-24 11:13:31CBER to launch Operation Warp Speed for rare diseases by year’s end
